February 15, 2012
Lung Cancer Treatment Doesn’t Improve Survival Rates
(Ivanhoe Newswire) -- A frequently administered treatment for lung cancer, postoperative radiation therapy (PORT), has been found to not extend life in patients with advanced lung cancer.
Patients who have non-small cell lung cancer most likely will have surgery to remove the tumor, but patients with stage III disease with an involvement of the lymph node called N2 will often be advised to use PORT.
“While some analyses have shown improvement with PORT, the data are not strong enough to support using it as a standard of care in older adults with this type of lung cancer. Our results show that we need more information about the potential benefits of radiation therapy before it is used routinely, especially considering the side effects associated with it. Our study indicates that clinicians should refrain from PORT in elderly patients with this cancer subtype until we know more. A randomized and controlled trial is required to fully assess any benefit, and such trials are ongoing now,” Vice-Chair for Research in the Department of Medicine at Mount Sinai School of Medicine and lead author on the study, Juan Wisnivesky, M.D.,DrPH., was quoted as saying.
SOURCE: Cancer, February 2012